Food industry spent $9 million lobbying against GMO labeling laws in first quarter

labelGMO

The food industry spent $9 million lobbying Congress to oppose laws requiring labeling for genetically modified products in the first quarter of this year, nearly matching its total spending for all of last year, a new report said.

The Washington D.C.-based Environmental Working Group said big spenders included the Grocery Manufacturers Association, which spent $1.2 million, and the Coca-Cola Co., which spent $2.6 million, on anti-labeling lobbying in the first three months of the year.

The group said that the total from lobbying expenditure forms citing genetically engineered labeling for the first quarter nearly matched the $9.3 million tallied in all of 2013. The increased spending underscores the pitched battle over labeling laws, which are being proposed in several states.

In May, Vermont became the first state to require labeling of genetically engineered products, a rule that is being challenged by the food industry in court. Oregon and Colorado will vote on labeling later this year.

Some major companies such as General Mills Inc. have spun skepticism over bioengineering into a marketing opportunity. Earlier this year, the food giant dropped genetically engineered ingredients from its signature Cheerios breakfast cereal.

Read the full, original article: Lobbying expenditures against GMO labeling soar this year

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
ChatGPT Image May 26, 2026, 08_42_17 AM (1)
Viewpoint: Greenpeace and poison: How environmental advocacy groups rely on compliant (and often ignorant) journalists to spread disinformation and spark litigation
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT Image May 26, 2026, 08_21_36 AM
Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.